MK-677 paradoxically increased leptin levels without reducing total body fat, and also raised testosterone while not affecting thyroid hormones, suggesting complex metabolic interactions beyond simple GH effects.
Leptin-fat disconnectLeptin rose significantly during MK-677 treatment despite no change in total body fat, suggesting direct adipocyte effects
What the researchers found
MK-677 increased serum leptin levels independent of body fat changes, increased testosterone, and had no effect on thyroid hormones in obese males, revealing metabolic effects dissociated from fat mass changes.
Why it matters
The leptin-fat disconnection suggests MK-677 directly affects adipocyte signaling. If MK-677 raises leptin without reducing fat, its metabolic effects are more complex than simple GH-mediated fat burning.
How the study worked
Randomized, double-blind, placebo-controlled parallel study in obese males. MK-677 25 mg/day or placebo for 8 weeks. Leptin, thyroid hormones, testosterone, and body composition measured.
What this study cannot tell us
Short 8-week duration may be insufficient for fat mass changes. The mechanism of leptin increase independent of fat mass is unknown. Small sample in obese males only.
How to read the evidence
Strong evidence from a well-designed RCT with comprehensive hormonal measurements, revealing unexpected metabolic findings.
When this study was published
Published in 1999. The complex metabolic effects of GH secretagogues continue to be studied.
The bigger picture
The assumption that GH secretagogues simply boost GH which then burns fat is too simplistic. MK-677's effects on leptin and other hormones suggest it modulates the metabolic network in ways that don't always align with GH effects alone.
Questions still open
- Does MK-677 directly stimulate leptin production from fat cells?
- Would longer treatment eventually reduce fat mass?
- Does the testosterone increase have clinical significance?
Common questions
Does MK-677 help with fat loss?
What does the leptin increase mean?
Read the original research
Discrepancy between serum leptin values and total body fat in response to the oral growth hormone secretagogue MK-677.
Clinical endocrinology, 50(4), 451-6
Citation
Svensson, J; Carlsson, B; Carlsson, L M; Jansson, J O; Bengtsson, B A. (1999). Discrepancy between serum leptin values and total body fat in response to the oral growth hormone secretagogue MK-677.. Clinical endocrinology, 50(4), 451-6.